ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 411 filers reported holding ENCOMPASS HEALTH CORP in Q4 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,132,965 | +18.2% | 31,744 | +19.1% | 0.00% | 0.0% |
| Q2 2023 | $1,805,230 | +24.7% | 26,661 | +0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,447,199 | +3.2% | 26,652 | +13.8% | 0.00% | 0.0% |
| Q4 2022 | $1,402,800 | +44.3% | 23,429 | +9.1% | 0.00% | +50.0% |
| Q3 2022 | $972,000 | -20.6% | 21,480 | -2.1% | 0.00% | -33.3% |
| Q2 2022 | $1,224,000 | -81.4% | 21,945 | +3.2% | 0.00% | -76.9% |
| Q1 2022 | $6,576,000 | +410.6% | 21,261 | +7.9% | 0.01% | +550.0% |
| Q4 2021 | $1,288,000 | -11.3% | 19,712 | +1.8% | 0.00% | -33.3% |
| Q3 2021 | $1,452,000 | +2.4% | 19,360 | +6.6% | 0.00% | 0.0% |
| Q2 2021 | $1,418,000 | -3.3% | 18,165 | +1.5% | 0.00% | -25.0% |
| Q1 2021 | $1,467,000 | +3.6% | 17,890 | +4.2% | 0.00% | 0.0% |
| Q4 2020 | $1,416,000 | +29.8% | 17,161 | +1.9% | 0.00% | +33.3% |
| Q3 2020 | $1,091,000 | +12.6% | 16,841 | +7.6% | 0.00% | 0.0% |
| Q2 2020 | $969,000 | +10.2% | 15,656 | +14.0% | 0.00% | -25.0% |
| Q1 2020 | $879,000 | – | 13,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |